Literature DB >> 1083877

Differentiation of lymphoid cells: B cell as a direct target and T cell as a regulator in lipopolysaccharide-enhanced induction of immunoglobulin production.

N Shinohara, M Kern.   

Abstract

The cells involved in the stimulatory effect of bacterial lipopolysaccharide (LPS) on the induction of immunoglobulin (Ig) production by rabbit spleen cells cultured in the absence of antigen has been analyzed. Addition of LPS caused a several-fold enhancement of both DNA synthesis and Ig production. These enhanced activities were not significantly affected by depletion of adherent cells in the spleen cell population. Although inactivation of splenic T cells by anti-thymocyte serum (ATS) treatment did not affect the enhancement of DNA synthesis due to LPS, such treatment did adversely affect the enhancement of Ig production by LPS. Furthermore, the enhancement of Ig production of ATS-treated spleen cells by LPS was found to be dependent on the number of thymocytes added. In addition, the prior incubation of ATS-treated spleen cells with LPS resulted in effective enhancement of Ig production when such ATS-treated spleen cells and thymocytes were combined after removal of LPS. An identical experiment, except that thymocytes instead of ATS-treated spleen cells received the prior incubation with LPS, did not result in enhancement of Ig production. Finally, the enhanced Ig production due to LPS was inhibited by hydroxyurea, a known inhibitor of cellular DNA synthesis. The relationship between the mitogenic activity of LPS on B cells, the regulatory function of T cells, and the enhancement of Ig production by LPS is discussed in relation to the contrasting reports concerning the cellular target of LPS.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083877

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Differentiation of lymphoid cells: evidence for a B-cell specific serum suppressor.

Authors:  M Kern
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

2.  Marmoset species variation in the humoral antibody response: in vivo and in vitro studies.

Authors:  N Gengozian; J R Kateley; D A Nickerson
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

3.  Effects of hydroxyurea on monoclonal antibody production induced by anti-mIgG and LPS stimulation on murine B cell hybridomas.

Authors:  Alicia Martín-López; Asterio Sánchez-Mirón; Francisco García-Camacho; Antonio Contreras-Gómez; Emilio Molina-Grima
Journal:  Cytotechnology       Date:  2010-05-21       Impact factor: 2.058

4.  B-lymphocyte activation with an extract of Nocardia brasiliensis.

Authors:  L Ortiz-Oritz; D E Parks; J S Lopez; W O Weigle
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

5.  Contrasting effects of H-2 and Mls immunization on the polyclonal mitogenicity of murine lymphocytes.

Authors:  A Matossian-Rogers
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

6.  Polyclonal activation of B lymphocytes by lipopolysaccharide requires macrophage-derived interleukin-1.

Authors:  R Bucala
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

7.  In vivo activation of mouse spleen lymphocytes by lipid A in carrier-free form.

Authors:  A Mita; H Ohta; T Mita
Journal:  Immunology       Date:  1982-02       Impact factor: 7.397

8.  Bacterial lipopolysaccharide-induced immunoglobulin synthesis by human blood lymphocytes partially depleted of monocytes.

Authors:  D S Sager; H E Jasin
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

Review 9.  Understanding how lipopolysaccharide impacts CD4 T-cell immunity.

Authors:  Jeremy P McAleer; Anthony T Vella
Journal:  Crit Rev Immunol       Date:  2008       Impact factor: 2.214

10.  Regulation of B-cell proliferative responses to lipopolysaccharide by a subclass of thymus T cells.

Authors:  M A Norcross; R T Smith
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.